US

COVID cases are cut in HALF: Seven-day average is down nearly 50% since its peak on January 12

The seven-day average for new coronavirus cases across the United States has fallen by nearly half since the nation’s peak on January 12.

Daily COVID-19 cases have been falling steadily over the past three weeks with only 123,907 new infections reported on Thursday.

The seven-day average has dropped to 130,569, as hospitalizations have also fallen to 88,668.

This is the first time that the number of people currently hospitalized with COVID-19 in the U.S. has fallen below 90,000 since November 27.

The U.S. still reported 3,705 coronavirus fatalities on Thursday, with the seven-day average for deaths falling to 2,997.

Nationwide, there have been more than 26.6million American infected with COVID-19 and 455,735 deaths.

The drop in new cases and hospitalizations comes as the vaccine rollout continues and as many states maintain mask mandates and social distancing requirements in public spaces. It also comes as the U.S. gets one step closer to having a single-dose coronavirus vaccine.

According to data compiled by the COVID Tracking Project, between the peak of the pandemic nationwide on January 12 and February 4, the seven-day average for cases has fallen nationwide by 47.5 percent to 130,569, pictured in orange

For the first time in weeks, the seven-day average is below 20,000 in all states. Texas has the highest average at 19,634

For the first time in weeks, the seven-day average is below 20,000 in all states. Texas has the highest average at 19,634

The drop in new cases and hospitalizations comes as the vaccine rollout continues. Pictured, a first responder vaccinates a woman in her car in New Hampshire on Thursday as 123,907 new infections were reported nationwide

The drop in new cases and hospitalizations comes as the vaccine rollout continues. Pictured, a first responder vaccinates a woman in her car in New Hampshire on Thursday as 123,907 new infections were reported nationwide

Hospitalizations have also falled below 90,000 for the first time since November 27, as pictured above

Hospitalizations have also falled below 90,000 for the first time since November 27, as pictured above

According to data compiled by the COVID Tracking Project, between the peak on January 12 and February 4, the the seven-day average for cases has fallen nationwide by 47.5 percent.

The number of tests being taken has fallen also, but only by 12.7 percent, not enough to quantify the drop in cases.

The effects of the decrease in cases is being felt across the country, with no state recording a seven-day average of more than 20,000 on Thursday.

This is the first time in weeks that the average remained under the 20,000 threshold in every state.

The state that came the closest is Texas which has a seven-day average of 19,637 new cases.

California was second with an average of 15,405. In mid-January, an average of 42,000 new cases a day was being reported in the state.

Florida, Georgia, New York, and North Carolina on Thursday all reported an average between 5,000 and 10,000 new cases.

The average is between 1,000 and 5,000 in 24 states, between 500 and 1,000 in nine states, and between 1 and 500 in the remaining 12 states.

Hawaii has the lowest seven-day average at 98 cases.

Last week, there were fewer than one million infections recorded in the U.S in a week for the first time in two months.

Case and hospitalizations are both on the decrease but deaths remain high with 3,705 new fatalities reported Thursday

Case and hospitalizations are both on the decrease but deaths remain high with 3,705 new fatalities reported Thursday

Over the last seven days, from January 28 to February 3, 934,661 COVID-19 cases were reported in the U.S., a DailyMail.com analysis shows.

This is the first time that the weekly total has been six figures since early November, when a total of 962,560 cases were recorded between November 7 and November 14.

Forty-four states are seeing a decline in cases, according to data from Johns Hopkins University.

While the death toll in the U.S. from COVID-19 still remains high, new models from the Centers for Disease Control and Prevention (CDC) also predict that February could see 38,000 fewer deaths than last month.

The CDC published new ‘ensemble’ forecasts, which combines 37 independent forecasts of coronavirus deaths over the next four weeks into one projection.

On the low end of the projection, the forecast suggests that 496,000 deaths could be reported by February 27, which is 38,679 fewer COVID-19 deaths than the 93,435 fatalities that were reported in January.

But on the high end of the projection, the death toll could rise of as many as 534,000 deaths, which would mean February would record just 679 fewer deaths than were recorded in January.

The forecast also predicts that between 11,300 and 22,600 deaths from the virus will be reported each week for the next four weeks.

If the death toll reaches 534,000, it means more people in the U.S. will have died from COVID-19 than the number of people who live in Atlanta.

The figure will also be greater than the number of lives lost in the U.S. to Alzheimer’s disease, diabetes, the flu, pneumonia, and strokes combined.

America’s death toll is the highest in the world despite the country accounting for less than five percent of the global population. 

The decline in cases is coming as the U.S. gets one step closer to having a single-dose coronavirus vaccine.

Johnson & Johnson asked the Food and Drug Administration (FDA) to authorize its vaccine on Thursday night.

Now that it has submitted its application for emergency use authorization, Johnson & Johnson’s vaccine could be greenlit within weeks.

The US has an agreement, signed last year under the Trump administration, for 100 million doses of Johnson & Johnson’s vaccine, which the company says it can deliver by June, pending authorization.

People arrive for their Covid-19 vaccine at the Auto Club Speedway in Fontana, California, on Tuesday

People arrive for their Covid-19 vaccine at the Auto Club Speedway in Fontana, California, on Tuesday

Sergeant Jennifer Callender (pictured left) of the Illinois Air National Guard administers a Pfizer Covid-19 vaccine to Virginia Persha at a vaccination center established at the Triton College in River Grove, Illinois, on Wednesday

Sergeant Jennifer Callender (pictured left) of the Illinois Air National Guard administers a Pfizer Covid-19 vaccine to Virginia Persha at a vaccination center established at the Triton College in River Grove, Illinois, on Wednesday

The drug maker’s application to the FDA follows its January 29 report in which it said the vaccine had a 66 percent rate of preventing infections in its large global trial.

The shot is also 57 percent effective in South Africa, where a variant of the virus that dulls vaccine effectiveness is spreading.

If regulators approve the vaccine, it would be the third shot made available to the American public after vaccines from Pfizer Inc/BioNTech SE and Moderna Inc were approved in December.

J&J’s single-shot vaccine could help boost supply and simplify the U.S. immunization campaign – and bring President Joe Biden closer to his goal of 150 million shots in arms in the first 100 days of his term.

It emerged on Thursday that Biden may also be considering sending masks to every single household in the U.S.

Officials told NBC News that the White House’s COVID-19 Response Team is currently assessing different ways of mailing face coverings to 328 million Americans.

It is currently unclear how much the plan will cost, how many masks would be sent to each household, what types of masks would be included in the package and if people are required to receive them.

Although the plan has been discussed by the administration’s top public health experts, no final proposal has been sent to Biden for approval.

Officials have called for better – or double – masks to be warn as COVID variants from the UK, South Africa and Brazil continue to spread across the country.




Source link

Related Articles

Back to top button